Mycofit is a prescription drug , it is a potent immunosuppressive agent which is used along or with other medicines to prevent the body from rejecting an organ transplant. To buy Mycofit or to know its price contact 3s corporation.
Manufacturer : Intas Pharmaceuticals Ltd
Strengths available : 500 mg
Form : Tablets
Dosage : Recommended dosage for Renal Transplant (ADULT)- Oral Mycofit 500mg Tablets should be initiated within 72 hours following transplantation. The recommended dose in renal transplant patients is 1g administered twice daily (2g daily dose).
Recommended dosage for Renal Transplant (PAEDIATRIC POPULATION AGED 2 to 18 YEARS)- 600mg/m2 administered orally twice daily (up to a maximum of 2g daily). Mycofit 500mg Tablets should only be prescribed to patients with a body surface area greater than 1.5 m2, at a dose of 1g twice daily (2g daily dose). As some adverse reactions occur with greater frequency in this age group compared with adults, temporary dose reduction or interruption may be required; these will need to take into account relevant clinical factors including severity of reaction.
Paediatric population < 2 years-There are limited safety and efficacy data in children below the age of 2 years.
These are insufficient to make dosage recommendations and therefore use in this age group is not recommended.
Recommended dosage for Cardiac Transplant (ADULTS) – Oral Mycofit 500mg Tablets should be initiated within 5 days following transplantation. The recommended dose in cardiac transplant patients is 1.5g administered twice daily (3g daily dose).
Recommended dosage for Hepatic Transplant (ADULTS) – IV Mycofit should be administered for the first 4 days following hepatic transplant, with oral Mycofit 500mg Tablets initiated as soon after this as it can be tolerated. The recommended oral dose in hepatic transplant patients is 1.5g administered twice daily (3g daily dose).
Use in special populations (Elderly) – The recommended dose of 1g administered twice a day for renal transplant patients and 1.5g twice a day for cardiac or hepatic transplant patients is appropriate for the elderly.
Recommended dosage for Renal Implant – In renal transplant patients with severe chronic renal impairment (glomerular filtration rate < 25 mL/min-1/1.73 m2), outside the immediate post-transplant period, doses greater than 1g administered twice a day should be avoided. These patients should also be carefully observed.
Storage : Do not store above 25°C
Common side effects are stomach pain or swelling, constipation, trouble with sleeping, nausea and vomiting, headache, pain in arms, legs and back, uncontrolled shaking of arms and legs, chest pain, severe difficulty in breathing, persistent diarrhea, swelling of face, lips ,eyelids, tongue, hands and feet, dizziness and fainting, black or starry stools, yellowing of skin and eyes and bloody or coffee colored vomit